KL-6, a Human MUC1 Mucin, Is Chemotactic for Human Fibroblasts

Article Properties
  • Language
    English
  • Publication Date
    1997/10/01
  • Indian UGC (journal)
  • Refrences
    45
  • Citations
    129
  • Yutaka Hirasawa Second Department of Internal Medicine, Ehime University School of Medicine, Onsen-gun, Ehime, Japan
  • Nobuoki Kohno Second Department of Internal Medicine, Ehime University School of Medicine, Onsen-gun, Ehime, Japan
  • Akihito Yokoyama Second Department of Internal Medicine, Ehime University School of Medicine, Onsen-gun, Ehime, Japan
  • Yoshikazu Inoue Second Department of Internal Medicine, Ehime University School of Medicine, Onsen-gun, Ehime, Japan
  • Masahiro Abe Second Department of Internal Medicine, Ehime University School of Medicine, Onsen-gun, Ehime, Japan
  • Kunio Hiwada Second Department of Internal Medicine, Ehime University School of Medicine, Onsen-gun, Ehime, Japan
Cite
Hirasawa, Yutaka, et al. “KL-6, a Human MUC1 Mucin, Is Chemotactic for Human Fibroblasts”. American Journal of Respiratory Cell and Molecular Biology, vol. 17, no. 4, 1997, pp. 501-7, https://doi.org/10.1165/ajrcmb.17.4.2253.
Hirasawa, Y., Kohno, N., Yokoyama, A., Inoue, Y., Abe, M., & Hiwada, K. (1997). KL-6, a Human MUC1 Mucin, Is Chemotactic for Human Fibroblasts. American Journal of Respiratory Cell and Molecular Biology, 17(4), 501-507. https://doi.org/10.1165/ajrcmb.17.4.2253
Hirasawa Y, Kohno N, Yokoyama A, Inoue Y, Abe M, Hiwada K. KL-6, a Human MUC1 Mucin, Is Chemotactic for Human Fibroblasts. American Journal of Respiratory Cell and Molecular Biology. 1997;17(4):501-7.
Refrences
Title Journal Journal Categories Citations Publication Date
Expression of MUC1 on myeloma cells and induction of HLA-unrestricted CTL against MUC1 from a multiple myeloma patient.

The Journal of Immunology
  • Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy
103 1994
Expression of MUC1 on myeloma cells and induction of HLA-unrestricted CTL against MUC1 from a multiple myeloma patient.

European Journal of Cell Biology
  • Science: Biology (General): Cytology
  • Science: Biology (General): Cytology
  • Science: Biology (General): Cytology
  • Science: Biology (General): Genetics
1993
Expression of MUC1 on myeloma cells and induction of HLA-unrestricted CTL against MUC1 from a multiple myeloma patient.

Cancer Research
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Medicine (General)
1992
Expression of MUC1 on myeloma cells and induction of HLA-unrestricted CTL against MUC1 from a multiple myeloma patient.

1992
Expression of MUC1 on myeloma cells and induction of HLA-unrestricted CTL against MUC1 from a multiple myeloma patient.

The American Journal of Pathology
  • Medicine: Medicine (General): Medical technology
  • Medicine: Pathology
  • Medicine: Medicine (General)
  • Medicine: Medicine (General)
1990
Citations
Title Journal Journal Categories Citations Publication Date
Disease progression and changes in KL-6 in patients with limited cutaneous systemic sclerosis-associated interstitial lung disease Respiratory Investigation
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the respiratory system
2024
Role of BAL and Serum Krebs von den Lungen-6 (KL-6) in Patients with Pulmonary Fibrosis

Biomedicines
  • Science: Biology (General)
  • Science: Biology (General)
  • Medicine: Medicine (General)
  • Medicine: Therapeutics. Pharmacology
  • Medicine: Public aspects of medicine: Toxicology. Poisons
2024
Baseline Blood Levels of Mucin-1 Are Associated with Crucial On-Treatment Adverse Outcomes in Patients with Idiopathic Pulmonary Fibrosis Receiving Antifibrotic Pirfenidone

Biomedicines
  • Science: Biology (General)
  • Science: Biology (General)
  • Medicine: Medicine (General)
  • Medicine: Therapeutics. Pharmacology
  • Medicine: Public aspects of medicine: Toxicology. Poisons
2024
The Promising Role of Oncomarkers CA 19-9 and CA 125 in the Diagnosis of Progressive Pulmonary Fibrosis

Ural Medical Journal 2024
Prediction of progressive pulmonary fibrosis in patients with anti-synthetase syndrome-associated interstitial lung disease

Clinical Rheumatology
  • Medicine: Medicine (General)
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the musculoskeletal system
5 2023
Citations Analysis
Category Category Repetition
Medicine: Medicine (General)77
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the respiratory system48
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system27
Medicine24
Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy16
Science: Biology (General)15
Medicine: Internal medicine: Medical emergencies. Critical care. Intensive care. First aid9
Science: Chemistry: Organic chemistry: Biochemistry8
Medicine: Therapeutics. Pharmacology8
Medicine: Internal medicine: Infectious and parasitic diseases7
Medicine: Public aspects of medicine: Toxicology. Poisons7
Medicine: Medicine (General): Medical technology7
Medicine: Surgery6
Medicine: Internal medicine6
Medicine: Pathology5
Science: Biology (General): Genetics5
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens5
Science4
Medicine: Pediatrics4
Science: Biology (General): Cytology4
Science: Microbiology4
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs4
Science: Science (General)3
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the digestive system. Gastroenterology3
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the genitourinary system. Urology2
Science: Human anatomy2
Science: Physics2
Geography. Anthropology. Recreation: Environmental sciences2
Technology: Environmental technology. Sanitary engineering2
Science: Biology (General): Ecology2
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the musculoskeletal system2
Science: Chemistry: General. Including alchemy2
Science: Chemistry2
Science: Physiology2
Technology: Chemical technology: Biotechnology2
Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system1
Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry1
Science: Botany: Plant ecology1
Medicine: Other systems of medicine1
Medicine: Surgery: Anesthesiology1
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the endocrine glands. Clinical endocrinology1
Technology: Chemical technology1
Medicine: Ophthalmology1
Medicine: Medicine (General): Medical physics. Medical radiology. Nuclear medicine1
Medicine: Internal medicine: Special situations and conditions: Industrial medicine. Industrial hygiene1
Medicine: Public aspects of medicine1
Medicine: Other systems of medicine: Miscellaneous systems and treatments1
The category Medicine: Medicine (General) 77 is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Circulating KL-6 Predicts the Outcome of Rapidly Progressive Idiopathic Pulmonary Fibrosis and was published in 1998. The most recent citation comes from a 2024 study titled The Promising Role of Oncomarkers CA 19-9 and CA 125 in the Diagnosis of Progressive Pulmonary Fibrosis. This article reached its peak citation in 2022, with 14 citations. It has been cited in 90 different journals, 26% of which are open access. Among related journals, the Respiratory Investigation cited this research the most, with 4 citations. The chart below illustrates the annual citation trends for this article.
Citations used this article by year